Metachronous hepatic metastases from gastric carcinoma: A multicentric survey

European Journal of Surgical Oncology

Volumn 35, Issue 5, 2009, Pages 486-491

  Tiberio, G A M ^a   Coniglio, A ^a   Marchet, A ^b   Marrelli, D ^c   Giacopuzzi, S ^d   Baiocchi, L ^a   Roviello, F ^c   de Manzoni, G ^d   Nitti, D ^b   Giulini, S M ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Gastric cancer; Hepatic metastases; Treatment

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; AGGRESSIVENESS; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; LIVER METASTASIS; LIVER SURGERY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; PATIENT CARE; PATIENT SATISFACTION; PATIENT SELECTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CARCINOMA; SURVIVAL RATE;

AGED; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 63049105640     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.12.017     Document Type: Article

References (24)

1. Dicken B.J., Bigam D.L., Cass C., et al. Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg 241 (2005) 27-39
2. D'Angelica M., Gonen M., Brennan M.F., et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240 (2004) 808-816
3. Jaeck D., Oussoultzoglou E., Rosso E., et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1051
4. Adam R. Developing strategies for liver metastases from colorectal cancer. Semin Oncol 13 (2007) 1431-1434
5. Shirabe K., Wakiyama S., Gion T., et al. Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB 8 (2006) 89-92
6. Chiche L., Ducreux M., Lebreton G., et al. Métastases hépatiques des cancers de l'estomac. In: Adam R., and Chiche L. (Eds). Chirurgie des métastases hépatiques de cancers non colorectaux non endocrine. Monographies de l'association Française de Chirurgie (2005), Arnette, Paris 45-59
7. Cascinu S., Labianca R., Barone C., et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 99 (2007) 580-582
8. Cocconi G., Carlini P., Gamboni A., et al. Cisplatin, epirubicin, leucovorin and 5-fluorourail (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. Ann Oncol 14 (2003) 1258-1263
9. Saiura A., Umekita N., Inoue S., et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepato-gastroenterology 49 (2002) 1062-1065
10. Okano K., Maeba T., Ishimura K., et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235 (2002) 86-91
11. Fujii K., Fujioka S., Kato K., et al. Resection of liver metastasis from gastric adenocarcinoma. Hepato-gastroenterology 48 (2001) 368-371
12. Miyazaki M., Itoh H., Nakagawa K., et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92 (1997) 490-493
13. Sakamoto Y., Ohyama S., Yamamoto J., et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133 (2003) 507-511
14. Shirabe K., Shimada M., Matsumata T., et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepato-gastroenterology 50 (2003) 1560-1563
15. Roh H.R., Suh K.S., Lee H.J., et al. Outcome of hepatic resection for metastatic gastric cancer. Am Surg 71 (2005) 95-99
16. Ambiru S., Miyazaki M., Ito H., et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181 (2001) 279-283
17. Imamura H., Matsuyama Y., Shimada R., et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96 (2001) 3178-3184
18. Ochiai T., Sasako M., Mizuno S., et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81 (1994) 1175-1178
19. Zacherl J., Zacherl M., Scheuba C., et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6 (2002) 682-689
20. Sakamoto Y., Sano T., Shimada K., et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95 (2007) 534-539
21. Koga R., Junji Y., Shigekazu O., et al. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. JJCO 37 (2007) 836-842
22. Adam R., Chiche L., Aloia T., et al. Hepatic resection for noncolorectal nonendocrine liver metastases. Ann Surg 244 (2006) 524-535
23. Marrelli D., Roviello F., De Stefano A., et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. J Am Coll Surg 198 (2004) 51-58
24. Marrelli D., De Stefano A., de Manzoni G., et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241 (2005) 247-255